Among the top 20 genes, tPA (degree = 71), MMP9 (degree = 66), and PAI-1 (degree = 46), which could serve as kernel targets of HXTF in PPA treatment, were identified. The gene discussed is PLAT; the disease is primary progressive aphasia.